Patient | Age, years | Sex | Preexisting ocular disease | Grade of nucleus density | Preop.VA, logMAR | IOP before PPV | Days to PPV |
1 | 72 | M | None | N 3 | 0.1 | 14 | 0 |
2 | 66 | M | None | N 3 | 0.2 | 16 | 0 |
3 | 78 | F | POAG | N 3 | 0.1 | 22 | 0 |
4 | 69 | M | None | N 3 | 0.3 | 14 | 7 |
5 | 76 | F | None | N 3 | 0.3 | 16 | 0 |
6 | 82 | M | NPDR | N 3 | 0.1 | 18 | 0 |
7 | 73 | F | None | N 3 | 0.2 | 15 | 0 |
8 | 67 | F | None | N 3 | 0.4 | 14 | 0 |
9 | 59 | M | None | N 3 | 0.4 | 18 | 8 |
10 | 81 | M | None | N 3 | 0.1 | 18 | 0 |
11 | 78 | M | None | N 3 | 0.1 | 17 | 0 |
12 | 73 | F | None | N 3 | 0.2 | 14 | 0 |
13 | 81 | F | None | N 3 | 0.2 | 13 | 0 |
14 | 77 | F | None | N 3 | 0.2 | 16 | 0 |
15 | 84 | M | None | N 3 | 0.1 | 17 | 0 |
16 | 77 | M | NPDR | N 3 | 0.2 | 19 | 0 |
17 | 75 | F | None | N 3 | 0.2 | 16 | 0 |
18 | 82 | M | None | N 3 | 0.1 | 16 | 0 |
19 | 75 | F | None | N 3 | 0.2 | 17 | 0 |
20 | 78 | M | POAG | N 3 | 0.2 | 20 | 0 |
21 | 82 | M | Dry AMD | N 3 | 0.1 | 15 | 0 |
22 | 90 | M | None | N 3 | 0.1 | 16 | 0 |
23 | 81 | F | None | N 3 | 0.2 | 17 | 0 |
24 | 76 | F | None | N 3 | 0.2 | 13 | 0 |
25 | 81 | M | None | N 3 | 0.2 | 16 | 0 |
26 | 78 | M | None | N 3 | 0.3 | 18 | 0 |
27 | 75 | F | None | N 3 | 0.3 | 15 | 0 |
28 | 73 | F | Dry AMD | N 3 | 0.2 | 14 | 0 |
29 | 71 | M | None | N 3 | 0.4 | 18 | 0 |
30 | 69 | M | None | N 3 | 0.4 | 16 | 0 |
31 | 72 | F | None | N 3 | 0.5 | 18 | 0 |